@Article{Styczyński2012,
journal="Contemporary Oncology/Współczesna Onkologia",
issn="1428-2526",
volume="16",
number="3",
year="2012",
title="Bortezomib has little ex vivo activity in chronic myeloid  	leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia",
abstract=" Aim of the study:  Resistance to imatinib is one of the most important issues in treatment of chronic myeloid leukemia (CML) patients. The objective of the study was to analyze the ex vivo drug resistance profile to bortezomib and 22 other anti­leukemic drugs, including three tyrosine kinase inhibitors (TKIs), in CML in comparison to acute myeloid leukemia (AML).    Material and methods : A total of 82 pa­tients entered the study, including   36 CML and 46 AML adults. Among CML patients, 19 had advanced disease,   16 were resistant to imatinib, and 6 had ABL-kinase domain mutations. The ex vivo drug resistance profile was studied by the MTT assay.    Results:  CML cells were more resistant than AML blasts to the following drugs: prednisolone, vincristine, doxorubicin, eto­poside, melphalan, cytarabine, fludarabine, thiotepa, 4-HOO-cyclophos­phamide, thioguanine, bortezomib, topotecan, and clofarabine. CML cells were 2-fold more sensitive to busulfan than AML cells. CML patients with clinical imatinib resistance had higher ex vivo resistance to vincristine, daunorubicin, etoposide, and busulfan. No significant differences to all tested drugs, including TKIs, were observed between CML patients with non-advanced and advan­ced disease. CML patients with mutation had higher ex vivo resistance to vincristine, idarubicin, thiotepa, and busulfan.    Conclusions : CML cells are ex vivo more resistant to most drugs than acute myeloid leukemia blasts. Busulfan is more active in CML than AML cells. In comparison to AML cells, bortezomib has little ex vivo activity in CML cells. No differences between CML subgroups in sensitivity to 3 tested TKIs were detected.",
author="Styczyński, Jan
and Gil, Lidia
and Czyżewski, Krzysztof
and Kołodziej, Beata
and Kuryło-Rafińska, Beata
and Lewandowski, Krzysztof
and Gniot, Michał
and Lewandowska, Maria
and Komarnicki, Mieczysław
and Wysocki, Mariusz",
pages="210--214",
doi="10.5114/wo.2012.29286",
url="http://dx.doi.org/10.5114/wo.2012.29286"
}